October 2026—In the never-ending search for new cancer biomarkers, there is always at least one new hopeful waiting in the wings, readying for a potential elevation (so to speak) to star status. Among the latest to generate buzz (at least in the form of oncologists asking about testing) are MTAP deletions. Could these be the latest to have a breakout role? There are many good reasons to think so, says Eric Vail, MD.
October 2026—Antibiotic resistance has changed dramatically. How laboratories detect antibiotic resistant infections and how patients are treated have not. “We treat patients with our best-guess drugs, and we make those guesses based on the types of infections we’re seeing in the patients we take care of and what our local antibiotic resistance rates look like,” says Romney Humphries, PhD, D(ABMM), M(ASCP).
October 2026—This conversation is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with representatives of a company to spotlight its laboratory solutions. He spoke on July 21 with Nick Fingland, PhD, PMP, senior director of R&D operations and science, BD, and Chris Farnsworth, PhD, D(ABCC), section head of clinical chemistry, WashU Medicine, and professor of pathology and immunology and of emergency medicine, Washington University. McGonnagle’s questions and their answers follow. The title of their talk: Where quality begins: the real impact of blood collection choices.
Watch the full conversation:
This roundtable discussion is sponsored by BD.
October 2026—We have all heard the latest claims that the American Medical Association—and the medical specialties it represents—is misusing CPT codes to overpay physicians. Whether these statements come from the Medicare Payment Advisory Commission, members of Congress, or any other group, it’s no wonder we pathologists feel under attack.
Interactive Product Guides
Use our comprehensive guides to view and compare instruments and software systems feature by feature.
FEATURED GUIDE: Hematology Analyzers
October 2026—Differential reviews, reference ranges, longitudinal data, AI, and information silos were front and center when CAP TODAY publisher Bob McGonnagle led a discussion online in early September about hematology analyzers and the needs of laboratories and clinicians.
PRODUCT GUIDE ROUNDTABLES
October 2026—Artificial intelligence studies in the realm of pathology increasingly demonstrate the impressive diagnostic performance of AI, but it is also worthwhile to understand what happens when these tools are incorporated into routine clinical practice. To this end, the authors evaluated the validation, implementation, and real-world impact of an AI–assisted decision-support tool for prostate needle biopsies within a fully digital pathology practice.
October 2026—Bladder cancer is diagnosed and monitored using cystoscopy, an invasive procedure in which a camera is inserted into the bladder. Because this type of cancer recurs in more than 50 percent of patients within five years, such patients require repeated cystoscopies for the rest of their lives, creating significant discomfort, cost, and clinical burden.
October 2026
Q. For laboratories that have a remote laboratory information system (LIS), what documentation is needed to show compliance with CAP checklist requirement GEN.42195 Remote LIS? Read answer.
Q. Practice and confidence make the biggest difference in microtomy speed. Are there minor details beginner histotechnologists might overlook that could hinder their progress? Read answer.
MARKETPLACE
October 2026—Thermo Fisher Scientific has launched the Thermo Scientific LabLink 360 Quality Assurance software, designed to help clinical laboratories simplify quality control workflows, accelerate QC review and decision-making, improve visibility into QC performance, and manage QC operations.